Product Information
CLINDA-TRETINOIN 1.2%-0.025% is a generic product labeled by Actavis Pharma, Inc., priced at $3.3975 per GM under NDC 00472179060. Its NADAC has been published 231 times since Sep 21, 2016.
FDA first approved this application on Jun 12, 2015. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12; .25 mg/g; mg/g
Manufacturer
Actavis Pharma, Inc.NDC
00472179060
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
CLINDAMYCIN PHOSPHATE; TRETINOINApproval Type
Generic (ANDA)
FDA Application
ANDA202564FDA Approved
6/12/2015
TE Code
AB1
On Market Since
7/5/2016
Pharmacological Classes
Price Statistics
The NADAC for CLINDA-TRETINOIN 1.2%-0.025% has been published 231 times since Sep 21, 2016, and over the history we have for it it has declined 66.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3975 per GM |
|---|---|
| All-time high | $9.9987 (Oct 11, 2017) |
| All-time low | $3.3975 (Aug 19, 2026) |
| 52-week high | $6.5652 |
| 52-week low | $3.3975 |
| Median price | $6.6995 |
| Average price | $7.2129 |
| Largest weekly change | -41.5% (Apr 17, 2024) |
| Weeks tracked | 231 |
| Tracking since | Sep 21, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLINDA-TRETINOIN 1.2%-0.025%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDA-TRETINOIN 1.2%-0.025%, manufactured by Actavis Pharma, Inc., is $3.3975 per GM (NDC 00472179060), effective Aug 19, 2026.
How has the price of CLINDA-TRETINOIN 1.2%-0.025% changed over time?
Over the history we have for it, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has declined 66.0%. It has been tracked across 231 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for CLINDA-TRETINOIN 1.2%-0.025%?
Since Sep 21, 2016, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has ranged from a low of $3.3975 (Aug 19, 2026) to a high of $9.9987 (Oct 11, 2017), with a median of $6.6995 per GM.
Are there cheaper alternatives to CLINDA-TRETINOIN 1.2%-0.025%?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLINDA-TRETINOIN 1.2%-0.025% in a comparable dosage form, but none are currently priced below it.
Who manufactures CLINDA-TRETINOIN 1.2%-0.025%?
CLINDA-TRETINOIN 1.2%-0.025% (NDC 00472179060) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.